当前位置:
【multi exchange crypto analytics trading dashboard with TradingView alerts】
时间:2026-04-04 05:40:23 出处:Trading Strategies阅读(143)
U.S.listed spot bitcoin ETFs ended March with $1.32 billion in net inflows to record their first monthly inflows since October,multi exchange crypto analytics trading dashboard with TradingView alerts SoSoValue data shows.\n\nThis follows four consecutive months of net outflows, which coincided with bitcoin declining by as much as 50% from its October all time high of $126,000. November saw $3.5 billion in outflows, followed by $1.1 billion in December, $1.6 billion in January, and $206 million in February.\n\nMarch also marked bitcoin’s first positive monthly candle in six months, suggesting a potential shift in momentum.\n\nETF assets under management have remained relatively resilient, however. Holdings declined from 1.38 million BTC in October to a low of 1.28 million BTC, a drop of roughly 7%, and have since recovered to around 1.31 million BTC, according to CheckonChain.\n\nETF investors remain underwater on average, with an estimated cost basis near $84,000 compared to a current spot price of about $68,000.
分享到:
上一篇: Citadel-backed EDX Markets applies for U.S. trust charter to expand institutional crypto services
下一篇: Oil trader takes $17 million hit as tokenized crude rivals bitcoin liquidations
温馨提示:以上内容和图片整理于网络,仅供参考,希望对您有帮助!如有侵权行为请联系删除!
猜你喜欢
- The Protocol: Quantum computing could break Bitcoin sooner, says Google
- Brazil's B3 exchange to offer bitcoin-linked 'event contracts' for the ultra-rich
- CoinDesk 20 performance update: Avalanche (AVAX) gains 4% as index moves higher
- Beyond T-bills: OpenEden introduces tokenized high-yield corporate bond
- Crypto Long & Short: Governance is the real Layer 1
- Jack Dorsey says AI should replace the middle manager after Block cuts 4,000 jobs
- Bitcoin traders keep chasing Trump’s Iran noise. The real signals are elsewhere.
- CoinDesk 20 performance update: Avalanche (AVAX) gains 4% as index moves higher
- Jamie Dimon signals JPMorgan entry into prediction markets as competition surges